Skip to main content
KANGSTEM BIOTECH CO., LTD. logo

KANGSTEM BIOTECH CO., LTD. — Investor Relations & Filings

Ticker · 217730 ISIN · KR7217730001 KO Manufacturing
Open in API
Filings indexed 414 across all filing types
Latest filing 2025-08-06 Director's Dealing
Country KR South Korea
Listing KO 217730

About KANGSTEM BIOTECH CO., LTD.

https://kangstem.com

KANGSTEM BIOTECH CO., LTD. is a biopharmaceutical company that researches and develops advanced stem cell therapies. The company focuses on creating treatments for rare, incurable, and autoimmune diseases, with a pipeline that includes therapeutic candidates for neurological disorders. Leveraging proprietary technologies for the isolation and mass culture of mesenchymal stem cells, Kangstem Biotech also develops and commercializes stem cell culture media and related cosmetic products. The company is dedicated to addressing unmet medical needs through the development of next-generation biopharmaceuticals.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed by Kang Kyung Sun for Kangstem Biotech. This type of filing is a standard regulatory requirement for insiders (directors/major shareholders) to disclose changes in their shareholdings, which falls under the 'Director's Dealing' category.
2025-08-06 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed by an executive (Choi Jung Ho) of Kangstem Biotech. This type of filing is a standard regulatory requirement for reporting insider transactions (director's dealings) in South Korea. It details the change in share ownership and specific securities held by the director. Therefore, it falls under the 'Director's Dealing' category.
2025-08-06 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the acquisition of shares and share warrants by '주식회사 세종' in '강스템바이오텍'. This type of filing is specifically categorized as a Major Shareholding Notification (MRQ) in the provided schema.
2025-08-06 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. This type of filing is a mandatory disclosure for major shareholders (10% or more) or executives regarding changes in their shareholdings. In the context of the provided categories, this falls under 'Major Shareholding Notification' (MRQ) as it details the change in ownership status of a major shareholder (Sejong Corp) in the issuing company (Kangstem Biotech).
2025-08-06 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service (FSS). This type of filing is a mandatory disclosure for major shareholders (10% or more) or executives when their shareholding status changes. In the context of the provided categories, this falls under 'Major Shareholding Notification' (MRQ) as it details a change in significant share ownership (specifically, the acquisition of new share warrants by a major shareholder, Sejong Corp).
2025-07-30 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed by Kangstem Biotech. This type of filing is a standard regulatory requirement for insiders (directors/major shareholders) to disclose changes in their shareholdings, which falls under the 'Director's Dealing' category (DIRS) in the provided taxonomy.
2025-07-29 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.